Document |
Document Title |
WO/2020/053713A1 |
A method of producing dimethoxyethane is disclosed. The method includes contacting molecules of dimethyl ether with a silver nano catalyst under reaction conditions suitable to couple the molecules of dimethyl ether and thereby form the ...
|
WO/2020/051887A1 |
Disclosed is a method for preparing propylene glycol monoethyl ether by means of a fixed bed reaction using a solid superbase as a catalyst. The method comprises the steps of: feeding ethanol and propylene oxide into a fixed bed reactor ...
|
WO/2020/049463A1 |
Systems and methods for producing MTBE and 1-butene are disclosed. A crude C4 hydrocarbon stream is obtained by removing butadiene from a C4 hydrocarbon mixture of a hydrocarbon cracking unit. The crude C4 hydrocarbon stream is then dist...
|
WO/2020/047372A1 |
Disclosed are novel substituted catechol monomers, polymers made with the substituted catechol monomers, pH responsive polymers made with the substituted catechol monomers, and related methods. Also provided is a method of preparing an a...
|
WO/2020/044825A1 |
A method for solvent purification which comprises distilling a solvent with distillation equipment 10 including a distillation vessel 1, thereby obtaining the solvent that has been purified. Members constituting the distillation equipmen...
|
WO/2020/045571A1 |
Provided is a production method for efficiently producing form II crystal of reduced coenzyme Q10. This production method for form II crystal of reduced coenzyme Q10 according to the present invention includes: formulating a liquid mixtu...
|
WO/2020/043518A1 |
A process to produce a mono vinylether of formula (I) R-O-CH=CH2 wherein R represents an organic group with at least three carbon atoms comprising a) reacting a mono hydroxy compound of formula (II) R-OH wherein R has the above meaning w...
|
WO/2020/039094A1 |
The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haemat...
|
WO/2020/037209A1 |
A series of benzosuberene analogues demonstrate effective inhibition of tubulin polymerization, cytotoxicity against human cancer cell lines, and vascular dismption in tumors.
|
WO/2020/037098A1 |
The present invention relates to novel ((4,4,8-trimethyltricyclo[6.3.1.02,5]dodecan-1-yl)oxy) alcohols and their use as fragrance materials.
|
WO/2020/030541A1 |
The present invention relates to a novel solid presentation form of a phenol derivative, characterized by a rounded portion and a flat portion. The compositions thus obtained have advantageous properties suitable for the storage, handlin...
|
WO/2020/024078A1 |
The present application provides a medicament having an anti-inflammatory bowel disease function, and a preparation method therefor and an application thereof. The medicament has a structure as represented in formula I or formula II. The...
|
WO/2020/021034A1 |
The present invention relates to the use of compounds of the generation (n) dendrimer type or the salts thereof, comprising: a central unit of valency 3 having formula (I), (n-1) inner generation layers consisting of repeat units having ...
|
WO/2020/014776A1 |
An oral dispersible film composition comprising at least one active ingredient and a film forming agent, as well as a method of manufacture of same. The oral dispersible film composition can be free of gum resin, and can be utilized to a...
|
WO/2020/014596A1 |
Described are compositions and methods for inhibiting polymerization of a monomer (e.g., styrene) composition, which use an N-O polymerization inhibitor, a quinone methide polymerization retarder, and an amine stabilizer having a primary...
|
WO/2020/010132A1 |
Provided are l,3,5-tris(6-methylpyridin-2-yloxy)benzene derivatives and related compounds that target the nucleotide-binding oligomerization domain, leucine rich repeat containing XI (NLRX1) pathway. The compounds can be used to treat mu...
|
WO/2020/008051A1 |
The present invention relates to a compound of the following formula (I): (I). The invention also relates to uses thereof as dye or pigment, notably as a luster pigment,and to areflective or photonic or nanophotonic or optoelectronic dev...
|
WO/2020/001166A1 |
Disclosed are a glycoside compound represented by formula (III) and a preparation method therefor, a composition, an application, and an intermediate. The provided glycoside compound is simple in preparation method, can remarkably improv...
|
WO/2020/001812A1 |
The present invention relates to a novel process for the preparation of SGLT-2 inhibitors via addition of a hydroxymethylene group in an open chain intermediate, readily accessible from D-glucose.
|
WO/2020/000252A1 |
A phosphate surfactant composition including a phosphate surfactant formed from a secondary alcohol alkoxylate.
|
WO/2020/006069A1 |
A method of producing one or more glycerol ethers, the method comprising contacting glycerol and tertiary butanol (TBA) in the presence of an acidic catalyst to produce one or more glycerol ethers selected from mono-tert butyl glycerol e...
|
WO/2020/004502A1 |
The present invention addresses the problem of providing a new method for synthesizing a fluorovinyl ether compound from a fluorine-containing vinyl compound, etc. To solve this problem, provided is a method for producing a compound repr...
|
WO/2019/246232A1 |
A method of obtaining a volatile or semi-volatile natural antioxidant by toasting a comestible byproduct, natural antioxidants obtained by toasting the comestible byproduct, and packaging films incorporating such natural antioxidants are...
|
WO/2019/243501A1 |
The present invention relates to compounds of formula (I) as properfume compounds. In particular, the present invention relates to a method to release a compound being a ketone or aldehyde of formula (II), a formate ester of formula (III...
|
WO/2019/240396A1 |
An embodiment of the present invention provides an epoxy reactive diluent, wherein in an epoxy reactive diluent composition, the content of a compound represented by chemical formula 1 below is 85 wt% or more relative to a total weight o...
|
WO/2019/231262A1 |
The present invention provides a novel biphenyl derivative compound or a pharmaceutically acceptable salt thereof. A biphenyl derivative compound or a pharmaceutically acceptable salt thereof, according to the present invention, is a sub...
|
WO/2019/231261A1 |
The present invention provides a novel biphenyl derivative compound, an optical isomer thereof, or a pharmaceutically acceptable salt thereof. The biphenyl derivative compound, an optical isomer thereof, and a pharmaceutically acceptable...
|
WO/2019/225742A1 |
Constructed is a technology capable of coupling organic compounds efficiently, inexpensively, simply, and in a short time by a small number of steps. A method for coupling organic compounds, wherein the method for coupling organic compou...
|
WO/2019/222244A1 |
This invention relates generally to the synthesis of Δ12-Prostaglandin J product using stereoretentive ruthenium olefin metathesis catalysts supported by dithiolate ligands. Δ12- Prostaglandin J products were generated with excellent s...
|
WO/2019/221267A1 |
Provided are: a novel liquid crystalline compound which can be used in an ionic conductor; an ionic conductor using the liquid crystalline compound; and an electrolytic film and secondary battery using the ionic conductor. This liquid cr...
|
WO/2019/218490A1 |
Provided is a method for directly preparing dimethyl ether by synthesis gas, the method comprises: the synthesis gas is passed through a reaction zone carrying a catalyst, and reacted under the reaction conditions sufficient to convert a...
|
WO/2019/216163A1 |
This 1,2,2,2-tetrafluoroethyl methyl ether production method includes: a step for obtaining a reaction mixture including hydrogen chloride, hydrogen fluoride, and a crude fluoral obtained by performing catalytic vapor phase fluorination ...
|
WO/2019/211877A1 |
The present invention discloses a novel process for the preparation of macrocyclic ketone analogs of halichondrin B or pharmaceutically acceptable salts thereof and to novel intermediates which are produced during the course of carrying ...
|
WO/2019/207137A1 |
The present invention relates to the use of esters and/or ethers of 3-methyl-pentane- diol and unsaturated derivates thereof as aroma chemicals, to aroma chemical compositions comprising at least one ester of 3-methyl-pentan-diol and/or ...
|
WO/2019/206324A1 |
A combined method for preparing methyl tert-butyl ether and isobutylene from tert-butyl alcohol and methanol. The method is carried out in a device comprising a catalytic rectification tower. The catalytic rectification tower comprises a...
|
WO/2019/203131A1 |
A composition containing an unsaturated double bond that is represented by general formula (I) or general formula (II); an oxygen absorbent comprising the same; and a resin composition.
|
WO/2019/196379A1 |
Disclosed is a method for catalyzing selective hydrogenolysis of lignin by a nickel-base material loaded by zirconium phosphate. The method is used for preparing a monophenol chemical substance by means of hydrogenolysis. The method comp...
|
WO/2019/198606A1 |
An alkenyl-group-containing compound represented by formula (1). (In formula (1), X represents any organic group; Y represents an alkenyl group, and when more than one Y is present, then the Y's may be the same or different; Z represents...
|
WO/2019/199863A1 |
Provided are compounds, or pharmaceutically acceptable salts thereof, which are useful for inhibiting FOXM1, inhibiting cancer growth, and/or treating cancer. In particular, these compounds and their corresponding quaternary ammonium sal...
|
WO/2019/198607A1 |
An alkenyl-group-containing compound represented by formula (1), wherein X has a Hansen solubility parameter in which the polarity term δP is 6 or greater. (In formula (1), X represents any organic group; Y represents an alkenyl group, ...
|
WO/2019/195014A1 |
A method for marking a petroleum hydrocarbon or a liquid biologically derived fuel; said method comprising adding to said petroleum hydrocarbon or liquid biologically derived fuel at least one compound that is a R1, R2, R3, R4, R5, R6, R...
|
WO/2019/185730A1 |
The invention relates to methods for synthesizing a biarylic compound from two arene compounds, comprising the step of reacting said arene compounds in the presence of an ordered, porous material, a catalytic transition metal and an 5 ox...
|
WO/2019/189188A1 |
Provided is a method for purifying a trityl group-containing monodispersed polyethylene glycol from a mixture containing a specific trityl group-containing monodispersed polyethylene glycol and specific ditrityl impurities, the method co...
|
WO/2019/191227A1 |
The present disclosure provides methods of reducing inflammation of the digestive system in a subject in need thereof, including subjects suffering from inflammatory bowel disease. Compositions for use in these methods are also provided.
|
WO/2019/191069A1 |
Implementations of a method of forming a wax ether composition may include: providing a batch of lipids, drying the batch of lipids, and cooling the batch of lipids. The method may also include dosing, with a catalyst, the batch of lipid...
|
WO/2019/184088A1 |
Disclosed are reaction carriers 1, 2 and 3 and a preparation method therefor and an application thereof. A reaction carrier 1/2/3 is used to synthesize angiotensin II, which can effectively increase the solubility of a full protective pe...
|
WO/2019/181984A1 |
Branched monodispersed polyethylene glycol represented by formula (1). (X1 is a functional group that reacts with a functional group present in a biofunctional molecule to form a covalent bond; n is an integer of 4-50 and represents the ...
|
WO/2019/177458A1 |
The invention relates to a demethoxylation process for demethoxylating alkylmethoxyphenols using an aromatic solvent to produce alkylphenols. The invention also relates to dealkylation process for dealkylating alkylphenols using an aroma...
|
WO/2019/174974A1 |
The invention relates to a fertilizer composition comprising a) zeolitic imidazolate framework ZIF-8; and b) a fertilizer selected from liquid or solid ammonium-containing inorganic fertilizers, liquid or solid organic fertilizers, and u...
|
WO/2019/174977A1 |
The invention relates to a composition comprising a) zeolitic imidazolate framework ZIF-8; and b) Compounds of formula (I) or a stereoisomer, salt, tautomer or N-oxide thereof, wherein the variables have a meaning as defined in the main ...
|